SCHEMBL5201589

SCHEMBL5201589

CSc1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)c(OCCNC(=O)OC(C)(C)C)c1.CSc1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)c(OCCNC(=O)OC(C)(C)C)c1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
KDM4E B2RXH2 1/20 0.58
F10 P00742 16/20 0.53
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HTT P42858 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
KLKB1 P03952 3/20 0.46
MITF O75030 1/20 0.45
KCNH2 Q12809 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3160329 1.00 NPC1 (0.58) NPC1RAB9AKDM4EF10KMT2A
SCHEMBL3161375 0.98 NPC1 (0.57) NPC1RAB9AKDM4EF10KMT2A
SCHEMBL3160045 0.94 NPC1 (0.55) NPC1RAB9AKDM4EF10KMT2A
SCHEMBL3157546 0.92 NPC1 (0.54) NPC1RAB9AKDM4EF10KMT2A
SCHEMBL4279973 0.89 NPC1 (0.55) NPC1RAB9AKDM4EF10KMT2A
SCHEMBL3152095 0.89 F10 (0.55) F10KLKB1KCNH2
SCHEMBL4285191 0.89 NPC1 (0.54) NPC1RAB9AKDM4EF10KMT2A
SCHEMBL4268954 0.87 NPC1 (0.54) NPC1RAB9AKDM4EF10KMT2A
SCHEMBL3161363 0.87 F10 (0.53) F10KLKB1KCNH2
SCHEMBL3160286 0.87 F10 (0.58) F10KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817287-A1 AROMATIC ETHER DERIVATIVES USEFUL AS THROMBIN INHIBITORS Eli Lilly and Company (US) 2007-08-15 EP disclosed
WO-2006057845-A1 AROMATIC ETHER DERIVATIVES USEFUL AS THROMBIN INHIBITORS ELI LILLY AND COMPANY (US) 2006-06-01 WO disclosed